Aspergillosis clinical trials at University of California Health
3 research studies open to eligible people
Olorofim Aspergillus Infection Study
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
at UC Davis UCSF
PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)
open to eligible people ages 18 years and up
To assess the safety and efficacy of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory IPA
at UCLA
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
open to eligible people ages up to 21 years
This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).
at UCSD UCSF
Our lead scientists for Aspergillosis research studies include Joanna M. Schaenman, MD, PhD.
Last updated: